Immunotherapy for Breast Cancer in Mexico

Functional Oncology Alternative Cancer Treatment

Breast cancer is one of the most commonly diagnosed cancers in the world, globally, nearly 1 out of 8 women in the world will be diagnosed with breast cancer. Until recently, breast cancer treatments typically involved surgery, radiation or chemotherapy depending on stage of the cancer because it was thought to be unresponsive to the immune system.

More recently, technological breakthrough and advancement in the world of cancer treatments have proven that in fact, breast cancer patients have improved outcomes when treated or combined treatments employ the use of immunotherapy for cancer and can post significant advantages in cost over conventional treatments involving chemotherapy.

How does Immunotherapy for Breast Cancer Work?

T-CELLS

T-cells are a type of white blood cell that can identify and kill infected, damaged or cancerous cells. Each T-cell has clawlike receptors on its surface that can recognize and lock onto antigens, foreign or abnormal protein fragments on the surface of infected or cancerous cells

ACTIVATING A T-CELL

T-CELLS

The T-cell must be activated before it can find and attack cancer cells. A specialized cell presents the T-cell with an antigen from a cancer cell, along with a co-stimulator protein. The T-cell begins to hunt down and kill any cells that are covered with the same antigen.

CANCER AND CHECKPOINTS

T-CELLS

Cancer cells can avoid destruction by taking advantage of a switch on the T-cell called an immune checkpoint. The checkpoint can shut down the T-cell and suppress the immune response, allowing the cancer to grow undisturbed.

“In the US, Immunotherapy for Breast Cancer can cost upward of $100,000 usd. Here with us in Tijuana, Mexico breast cancer patients are saving over 75% of the cost as part of our functional oncology treatment program and receiving over 90% benefit rate over traditional treatments”

Breast Cancer Survival Rates

Functional Oncology Program Benefit Statistics

The patient survival statistics are a small representation of the overall outcomes recorded by patients that underwent at least one of our cancer treatments and have approved our use of their information for statistical record keeping.

These numbers are intended to provide patients a general overlook at possible outcomes per type of condition but it’s important to understand that every patient’s cancer treatment and illness is treated different and can produce very different outcomes based on many aspects that should be discussed individually with your doctor despite our best intention to provide measurable baseline information for the consideration of our program.

Cancer Type

Case Number

Stage I

Stage II

Stage III

Stage IV

Benefit Rate (%)

Lung Cancer

1067

33

97

408

428

90%

Pancreatic Cancer

195

3

11

32

87

93%

Breast Cancer

125

2

3

16

67

88%

Ovarian Cancer

52

0

3

9

28

92%

Colon Cancer

47

0

1

5

28

87%

Lymphoma

40

2

9

8

4

93%

Cervical Cancer

24

1

1

5

12

96%

Bladder Cancer

11

0

1

0

4

100%

Cancer Type

Case Number

Benefit Rate (%)

Lung Cancer

1067

90%

Pancreatic Cancer

195

93%

Breast Cancer

125

88%

Ovarian Cancer

52

92%

Colon Cancer

47

87%

Lymphoma

40

93%

Cervical Cancer

24

96%

Bladder Cancer

11

100%

Request More Information

Notice: JavaScript is required for this content.

Angeles Hospital is Mexico’s largest private hospital network. Our patient care network is comprised of 28 hospitals, 234 surgical suites, 2,554 beds and 15,000 specialists. Five million patients are treated each year by 11,000 Angeles Health physicians. We take pride in our work and seek to provide the best hospital experience for all of our patients. We hope that you will join us soon.